Tibet Rhodiola Pharmaceutical Holding Co.

SHSE:600211 Stock Report

Market Cap: CN¥12.3b

Tibet Rhodiola Pharmaceutical Holding Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yuan Dong Guo

Chief executive officer

CN¥3.4m

Total compensation

CEO salary percentagen/a
CEO tenure7.5yrs
CEO ownershipn/a
Management average tenure7.5yrs
Board average tenure7.5yrs

Recent management updates

Recent updates

At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?

Sep 25
At CN¥33.30, Is Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Worth Looking At Closely?

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Sep 02
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Could Easily Take On More Debt

Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Jul 29
Insufficient Growth At Tibet Rhodiola Pharmaceutical Holding Co. (SHSE:600211) Hampers Share Price

Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Jul 12
Investors Shouldn't Overlook Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Impressive Returns On Capital

Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

May 21
Tibet Rhodiola Pharmaceutical Holding (SHSE:600211) Seems To Use Debt Rather Sparingly

Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

May 03
Shareholders Will Be Pleased With The Quality of Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Earnings

Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

Mar 22
Under The Bonnet, Tibet Rhodiola Pharmaceutical Holding's (SHSE:600211) Returns Look Impressive

CEO

Yuan Dong Guo (52 yo)

7.5yrs

Tenure

CN¥3,437,900

Compensation

Mr. Yuan Dong Guo serves as General Manager and Director of Tibet Rhodiola Pharmaceutical Holding Company since May 8, 2017. Mr. Guo served as the Chairman of the Board of Directors and Deputy General Mana...


Leadership Team

NamePositionTenureCompensationOwnership
Yuan Dong Guo
GM & Director7.5yrsCN¥3.44mno data
Jun Chen
Financial Director5.1yrsCN¥736.70kno data
Lan Liu
Deputy GM & Secretary of the Board7.5yrsCN¥1.07mno data

7.5yrs

Average Tenure

52yo

Average Age

Experienced Management: 600211's management team is seasoned and experienced (7.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Yuan Dong Guo
GM & Director7.5yrsCN¥3.44mno data
Dabin Chen
Chairman of the Board7.5yrsCN¥3.44mno data
Yu Cheng Zhou
Vice Chairman of the Board7.5yrsCN¥1.81mno data
Pei Yao
Chairman of the Supervisory Board7.5yrsno datano data
Sanyan Wu
Director4.5yrsCN¥80.00kno data
Ma Lie Yi
Director7.5yrsCN¥80.00kno data
Tiantian Tang
Supervisor5.6yrsno datano data
Yu Zhang
Independent Director2.9yrsCN¥180.00kno data

7.5yrs

Average Tenure

49.5yo

Average Age

Experienced Board: 600211's board of directors are considered experienced (7.5 years average tenure).